LFCR - LIFECORE BIOMEDICAL, INC. \DE\
6.95
-0.070 -1.007%
Share volume: 206,604
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$7.02
-0.07
-0.01%
View ratios
| Fiscal Date | 02-26-2023 | 05-28-2023 | 11-26-2023 | 02-25-2024 | 05-26-2024 | 08-25-2024 | 11-24-2024 | 02-23-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2023 | Q4 2023 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 06-02-2023 | 03-20-2024 | 08-09-2024 | 08-09-2024 | 01-02-2025 | 10-04-2024 | 01-02-2025 | 04-03-2025 | |
| Total revenue | 27.600 M | -6.488 M | 30.150 M | 35.704 M | 37.885 M | 24.705 M | 32.564 M | 35.154 M | |
| Cost of revenue | 21.622 M | -15.135 M | 20.193 M | 23.810 M | 20.614 M | 19.318 M | 21.480 M | 25.309 M | |
| Gross profit | 5.978 M | 8.647 M | 9.957 M | 11.894 M | 17.271 M | 5.387 M | 11.084 M | 9.845 M | |
| 44.65% | 15.15% | 19.45% | 45.21% | -68.81% | 105.75% | -11.18% | |||
| Operating expenses | 12.936 M | 9.169 M | 11.440 M | 12.018 M | 14.385 M | 16.971 M | 13.043 M | 12.138 M | |
| Selling general and admin | 10.972 M | 6.563 M | 9.342 M | 9.848 M | 12.224 M | 14.785 M | 11.119 M | 10.093 M | |
| Research and development | 1.964 M | 2.606 M | 2.098 M | 2.170 M | 2.161 M | 2.186 M | 1.924 M | 2.045 M | |
| Total expenses | 34.558 M | -5.966 M | 11.440 M | 12.789 M | 15.123 M | 16.971 M | 13.043 M | 18.874 M | |
| -117.26% | 291.75% | 11.79% | 18.25% | 12.22% | -23.15% | 44.71% | |||
| Operating income | -6.958 M | -522.000 K | -1.483 M | -895.000 K | 2.148 M | -11.584 M | -1.959 M | -9.029 M | |
| Ebit | -6.958 M | -522.000 K | 18.250 M | 19.291 M | -1.353 M | -10.887 M | -1.063 M | -9.296 M | |
| Pretax income | -15.391 M | -24.745 M | 14.177 M | 15.002 M | -7.143 M | -16.255 M | -6.528 M | -14.777 M | |
| 60.78% | -157.29% | 5.82% | -147.61% | 127.57% | -59.84% | 126.36% | |||
| Income tax | 70.000 K | 230.000 K | -65.000 K | 217.000 K | -57.300 K | -25.000 K | 43.000 K | -8.000 K | |
| Net income basic | -40.192 M | -35.571 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 11.50% | 100.00% | ||||||||
| Net income | -40.192 M | -35.571 M | 14.218 M | 15.632 M | -7.083 M | -16.230 M | -6.571 M | -14.769 M | |
| 11.50% | 139.97% | 9.95% | -145.31% | -129.14% | 59.51% | -124.76% |
